Icad Capex To Revenue vs Free Cash Flow Yield Analysis
| ICAD Stock | USD 1.58 0.04 2.60% |
Icad financial indicator trend analysis is infinitely more than just investigating icad inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether icad inc is a good investment. Please check the relationship between Icad Capex To Revenue and its Free Cash Flow Yield accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Capex To Revenue vs Free Cash Flow Yield
Capex To Revenue vs Free Cash Flow Yield Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of icad inc Capex To Revenue account and Free Cash Flow Yield. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Icad's Capex To Revenue and Free Cash Flow Yield is -0.02. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of icad inc, assuming nothing else is changed. The correlation between historical values of Icad's Capex To Revenue and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of icad inc are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Capex To Revenue i.e., Icad's Capex To Revenue and Free Cash Flow Yield go up and down completely randomly.
Correlation Coefficient | -0.02 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Most indicators from Icad's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into icad inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. The current year's Selling General Administrative is expected to grow to about 9.6 M, whereas Tax Provision is projected to grow to (97.8 K).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 35.0M | 33.7M | 22.2M | 20.0M | Cost Of Revenue | 9.4M | 8.1M | 2.8M | 2.6M |
Icad fundamental ratios Correlations
Click cells to compare fundamentals
Icad Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Icad fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 41.7M | 55.6M | 62.2M | 51.7M | 41.4M | 43.2M | |
| Short Long Term Debt Total | 22.5M | 8.8M | 1.2M | 3.4M | 461K | 438.0K | |
| Other Current Liab | 6.6M | 7.0M | 5.6M | 11.8M | 2.4M | 3.4M | |
| Total Current Liabilities | 18.8M | 16.8M | 15.0M | 13.5M | 6.7M | 9.3M | |
| Total Stockholder Equity | 5.1M | 30.5M | 46.5M | 34.9M | 33.4M | 28.7M | |
| Property Plant And Equipment Net | 3.0M | 2.5M | 1.9M | 4.4M | 2.3M | 2.1M | |
| Net Debt | 7.2M | (18.4M) | (33.1M) | (17.9M) | (21.2M) | (20.1M) | |
| Retained Earnings | (224.3M) | (241.9M) | (253.2M) | (266.8M) | (271.7M) | (258.1M) | |
| Cash | 15.3M | 27.2M | 34.3M | 21.3M | 21.7M | 22.8M | |
| Non Current Assets Total | 12.6M | 13.3M | 11.9M | 13.5M | 11.7M | 23.3M | |
| Non Currrent Assets Other | 50K | 1.5M | 899K | 54K | 849K | 891.5K | |
| Cash And Short Term Investments | 15.3M | 27.2M | 34.3M | 21.3M | 21.7M | 22.8M | |
| Net Receivables | 9.8M | 10.5M | 10.8M | 6.5M | 6.4M | 5.7M | |
| Common Stock Shares Outstanding | 18.4M | 22.1M | 24.8M | 25.2M | 25.6M | 26.9M | |
| Liabilities And Stockholders Equity | 41.7M | 55.6M | 62.2M | 51.7M | 41.4M | 43.2M | |
| Non Current Liabilities Total | 17.8M | 8.3M | 712K | 3.4M | 1.3M | 1.2M | |
| Inventory | 2.6M | 3.1M | 4.2M | 5.4M | 917K | 871.2K | |
| Other Current Assets | 1.5M | 1.5M | 1.1M | 9.2M | 699K | 804.7K | |
| Other Stockholder Equity | 229.2M | 272.2M | 299.4M | 301.5M | 304.8M | 320.1M | |
| Total Liab | 36.7M | 25.1M | 15.7M | 16.8M | 8.0M | 14.5M | |
| Property Plant And Equipment Gross | 3.0M | 2.5M | 8.0M | 6.6M | 3.3M | 2.3M | |
| Total Current Assets | 29.2M | 42.3M | 50.3M | 38.2M | 29.7M | 19.9M | |
| Intangible Assets | 1.2M | 889K | 683K | 482K | 148K | 140.6K | |
| Short Term Debt | 5.0M | 726K | 889K | 217K | 188K | 178.6K | |
| Accounts Payable | 2.0M | 2.9M | 2.8M | 1.4M | 712K | 676.4K | |
| Common Stock Total Equity | 171K | 196K | 236K | 253K | 227.7K | 216.1K | |
| Common Stock | 196K | 236K | 253K | 254K | 265K | 215.4K | |
| Other Assets | 50K | 3.3M | 899K | 185K | 1.0 | 0.95 | |
| Long Term Debt | 5.1M | 4.3M | 2.0M | 7.0M | 8.0M | 4.3M | |
| Property Plant Equipment | 551K | 2.5M | 1.9M | 4.4M | 5.1M | 5.4M | |
| Current Deferred Revenue | 5.2M | 6.1M | 5.7M | 6.2M | 3.4M | 4.6M | |
| Other Liab | 361K | 359K | 271K | 446K | 401.4K | 381.3K | |
| Net Tangible Assets | (4.5M) | 21.3M | 37.5M | 26.1M | 23.5M | 16.2M | |
| Retained Earnings Total Equity | (201.9M) | (210.8M) | (224.3M) | (253.2M) | (227.9M) | (216.5M) | |
| Capital Surpluse | 217.4M | 218.9M | 230.6M | 300.9M | 346.0M | 236.9M | |
| Deferred Long Term Liab | 520K | 334K | 359K | 446K | 401.4K | 653.4K | |
| Non Current Liabilities Other | 119K | 7.0M | 13.6M | 266K | 305.9K | 290.6K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether icad inc is a strong investment it is important to analyze Icad's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icad's future performance. For an informed investment choice regarding Icad Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.20) | Revenue Per Share 0.718 | Quarterly Revenue Growth 0.206 | Return On Assets (0.08) | Return On Equity (0.15) |
The market value of icad inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.